Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Yazar
Verbeek, Marcel M.
Trislan-Noguero, Alba
Borras, Eva
Molero-Luis, Marta
Wassenberg, Tessa
Peters, Tessa
Willemsen, Michel
Opladen, Thomas
Jeltsch, Kathrin
Pons, Roser
Thony, Beat
Horvath, Gabriella
Yapici, Zuhal
Friedman, Jennifer
Hyland, Keith
Agosta, Guillermo E.
Lopez-Laso, Eduardo
Artuch, Rafael
Sabido, Eduard
Garcia-Cazorla, Angels
Üst veri
Tüm öğe kaydını göster
Özet
Background Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia.
Bağlantı
http://hdl.handle.net/20.500.12627/2755
https://doi.org/10.1002/mds.28362
Koleksiyonlar